(IBDS) iShares iBonds Dec 2027 - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46435UAA97 • Target Maturity
IBDS: Investment-Grade, Corporate, U.S., Dollar-Denominated, 2027-Maturity
The iShares iBonds Dec 2027 Term Corporate ETF (IBDS) is designed to track the performance of the Bloomberg Barclays U.S. Corporate Index, focusing on investment-grade corporate bonds maturing in 2027. The fund adheres to a strict investment policy, allocating at least 80% of its assets to the component securities of the underlying index and at least 90% to fixed-income securities included in the index. This approach ensures a high level of alignment with the target index, minimizing tracking error. The ETFs underlying index is composed of U.S. dollar-denominated, investment-grade corporate bonds, specifically those maturing in 2027, providing investors with exposure to a defined maturity profile. By holding bonds until maturity, the fund seeks to deliver returns that align with the underlying securities, offering a predictable income stream as bonds approach their maturity dates.
From a technical perspective, IBDS has shown stability in recent trading sessions, with its 20-day, 50-day, and 200-day moving averages converging around the $24.00 level. The average trading volume of 508,350 shares over the past 20 days indicates moderate liquidity, while the Average True Range (ATR) of 0.08 reflects low volatility. This suggests that the ETF is trading in a narrow range with minimal price fluctuations, making it suitable for investors seeking stable exposure to corporate bonds. The last price of $24.21 is slightly above the 20-day SMA of $24.09, indicating a neutral to slightly bullish short-term trend.
From a fundamental perspective, the ETF manages $2.966 billion in assets under management (AUM), demonstrating its popularity among investors seeking targeted exposure to corporate bonds with a specific maturity. The funds focused investment strategy and significant AUM suggest efficient tracking of the underlying index and a diversified portfolio of corporate bonds. As interest rates remain low, the funds holdings are less sensitive to rate changes, providing a relatively stable return profile. However, as the 2027 maturity date approaches, the funds composition will shift, and investors should monitor the roll-off of maturing bonds and the potential reinvestment of proceeds.
Over the next three months, IBDS is expected to maintain its stable trading range, with prices fluctuating between $24.00 and $24.30 based on the convergence of its moving averages. The low ATR of 0.08 suggests that volatility will remain subdued, with minimal downside risk. From a fundamental perspective, the funds AUM is expected to remain steady, supported by its targeted maturity strategy and the ongoing demand for investment-grade corporate bonds. The funds returns will continue to reflect the performance of its underlying securities, with yields remaining consistent as the bonds approach maturity. Overall, IBDS is expected to provide a predictable return profile with minimal volatility over the next quarter.
Additional Sources for IBDS ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IBDS ETF Overview
Market Cap in USD | 2,994m |
Category | Target Maturity |
TER | 0.10% |
IPO / Inception | 2017-09-12 |
IBDS ETF Ratings
Growth Rating | 24.4 |
Fundamental | - |
Dividend Rating | 71.7 |
Rel. Strength | -3.75 |
Analysts | - |
Fair Price Momentum | 23.62 USD |
Fair Price DCF | - |
IBDS Dividends
Dividend Yield 12m | 4.45% |
Yield on Cost 5y | 4.90% |
Annual Growth 5y | 7.44% |
Payout Consistency | 95.1% |
IBDS Growth Ratios
Growth Correlation 3m | 88.2% |
Growth Correlation 12m | 93.8% |
Growth Correlation 5y | -5% |
CAGR 5y | 2.17% |
CAGR/Max DD 5y | 0.14 |
Sharpe Ratio 12m | -0.71 |
Alpha | 2.32 |
Beta | -0.004 |
Volatility | 2.53% |
Current Volume | 413.5k |
Average Volume 20d | 412k |
As of May 09, 2025, the stock is trading at USD 24.10 with a total of 413,466 shares traded.
Over the past week, the price has changed by -0.08%, over one month by +0.74%, over three months by +1.53% and over the past year by +6.50%.
Neither. Based on ValueRay Analyses, iShares iBonds Dec 2027 is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 24.41 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBDS as of May 2025 is 23.62. This means that IBDS is currently overvalued and has a potential downside of -1.99%.
iShares iBonds Dec 2027 has no consensus analysts rating.
According to ValueRays Forecast Model, IBDS iShares iBonds Dec 2027 will be worth about 25.5 in May 2026. The stock is currently trading at 24.10. This means that the stock has a potential upside of +5.85%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 25.5 | 5.9% |